CA Stock MarketDetailed Quotes

GLAB Gemina Laboratories Ltd

Watchlist

0.770
+0.025+3.36%

15min DelayMarket Closed Nov 29 10:24 ET

57.42MMarket Cap-19250P/E (TTM)

Gemina Laboratories Ltd Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jul 31, 2024

(Q1)Apr 30, 2024

(FY)Jan 31, 2024

(Q4)Jan 31, 2024

(Q3)Oct 31, 2023

(Q2)Jul 31, 2023

(Q1)Apr 30, 2023

(FY)Jan 31, 2023

(Q4)Jan 31, 2023

(Q3)Oct 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

68.92%-284.56K

61.01%-804.51K

28.07%-3.24M

102.71%8.26K

88.34%-273.06K

11.45%-915.45K

-148.92%-2.06M

-16.47%-4.51M

75.36%-304.73K

-80.37%-2.34M

Net income from continuing operations

38.62%-968.61K

51.71%-825.24K

12.75%-5.22M

61.06%-761.66K

6.67%-1.17M

20.71%-1.58M

-118.76%-1.71M

-26.28%-5.98M

-49.59%-1.96M

17.62%-1.25M

Depreciation and amortization

29.84%26.81K

43.34%26.81K

85.69%93.37K

86.20%26.61K

179.05%27.41K

57.75%20.65K

42.97%18.7K

14.71%50.28K

19.18%14.29K

-8.28%9.82K

Remuneration paid in stock

-43.99%102.7K

-52.78%84.42K

43.79%565.01K

-45.95%97.67K

-26.49%105.22K

107.61%183.35K

1,031.83%178.78K

-44.05%392.95K

55.66%180.69K

-9.53%143.14K

Other non cashItems

723.17%60.57K

258.03%23.63K

389.93%50.7K

-1,380.72%-268.41K

1,199.79%305.15K

67.84%7.36K

974.92%6.6K

152.08%10.35K

-1,949.69%-18.13K

2,691.56%23.48K

Change In working capital

9.45%493.98K

79.57%-114.13K

24.43%1.26M

-36.94%914.06K

136.70%457.27K

-47.19%451.33K

-1,220.73%-558.63K

799.59%1.02M

2,586.15%1.45M

-2,535.68%-1.25M

-Change in receivables

-96.91%6.58K

98.75%-636

272.67%347.23K

-51.78%155.19K

105.41%30.26K

599.49%212.65K

-954.61%-50.88K

-15.61%-201.09K

158.66%321.88K

-222.17%-559.31K

-Change in prepaid assets

-1,474.91%-77.64K

-166.62%-7.75K

212.57%66.6K

77.75%52.09K

124.27%7.81K

92.26%-4.93K

57.70%11.64K

-175.27%-59.17K

297.06%29.3K

12.48%-32.16K

-Change in payables and accrued expense

131.94%565.05K

79.64%-105.74K

-33.38%850.2K

-35.65%706.78K

164.06%419.21K

-72.56%243.62K

-833.64%-519.39K

313.84%1.28M

677.68%1.1M

-350.25%-654.42K

Cash from discontinued investing activities

Operating cash flow

68.92%-284.56K

61.01%-804.51K

28.07%-3.24M

102.50%8.26K

88.24%-273.06K

11.11%-915.45K

-148.92%-2.06M

-16.47%-4.51M

73.34%-329.73K

-78.76%-2.32M

Investing cash flow

Cash flow from continuing investing activities

91.81%-41.35K

103.58%16.26K

79.81%-12.06K

-354.69%-11.46K

-857.60%-34.09K

-6,261.63%-505.07K

-3,026.53%-454.34K

-2,567.98%-59.73K

Net PPE purchase and sale

--0

48.06%-41.35K

164.67%16.26K

77.86%-12.06K

---11.46K

---34.09K

-712.13%-79.61K

-344.65%-25.14K

-2,518.99%-54.48K

Net investment purchase and sale

----

--0

----

---429.21K

----

Net other investing changes

----

-79.17%3.75K

--0

-216.67%-5.25K

Cash from discontinued investing activities

Investing cash flow

--0

91.81%-41.35K

103.58%16.26K

79.81%-12.06K

-354.69%-11.46K

-857.60%-34.09K

-6,261.63%-505.07K

-3,026.53%-454.34K

-2,567.98%-59.73K

Financing cash flow

Cash flow from continuing financing activities

2,523.37%489.74K

-73.83%805.19K

-18.74%3.2M

-109.36%-26.42K

1,277.96%172.96K

-100.55%-20.21K

10,447.42%3.08M

-4.75%3.94M

60.05%282.33K

-99.39%12.55K

Net issuance payments of debt

-33.79%-27.04K

5,055.63%832.35K

272.60%109.54K

-57.31%-26.42K

1,574.78%172.96K

-15.68%-20.21K

3.86%-16.8K

6.29%-63.46K

28.83%-16.8K

64.56%-11.73K

Net common stock issuance

--0

-39.39%2.6M

--0

--2.6M

77.78%4.3M

--0

Proceeds from stock option exercised by employees

--516.78K

--0

100.00%600K

--0

--600K

50.00%300K

--0

Net other financing activities

---1

75.61%-27.16K

81.22%-111.35K

--0

-808.03%-111.35K

-137.33%-592.94K

-87,400.00%-873

-53.20%24.28K

Cash from discontinued financing activities

Financing cash flow

2,523.37%489.74K

-73.83%805.19K

-18.74%3.2M

-109.36%-26.42K

1,277.96%172.96K

-100.55%-20.21K

10,447.42%3.08M

-4.75%3.94M

60.05%282.33K

-99.39%12.55K

Net cash flow

Beginning cash position

-99.84%1.67K

-98.81%990

-92.81%83.1K

-99.50%2.9K

-96.10%115.06K

251.49%1.06M

-92.81%83.1K

31.12%1.16M

-73.43%584.84K

106.05%2.95M

Current changes in cash

121.66%205.18K

-99.93%675

92.35%-82.11K

99.62%-1.91K

95.26%-112.16K

-135.73%-947.12K

214.62%979.09K

-491.08%-1.07M

51.98%-501.75K

-408.28%-2.37M

End cash Position

79.78%206.85K

-99.84%1.67K

-98.81%990

-99.50%2.9K

-96.10%115.06K

251.49%1.06M

-92.81%83.1K

-73.43%584.84K

Free cash from

69.30%-284.56K

61.64%-804.51K

28.42%-3.29M

106.91%24.52K

88.00%-285.12K

10.00%-926.92K

-153.03%-2.1M

-18.23%-4.59M

71.07%-354.87K

-82.66%-2.38M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jul 31, 2024	(Q1)Apr 30, 2024	(FY)Jan 31, 2024	(Q4)Jan 31, 2024	(Q3)Oct 31, 2023	(Q2)Jul 31, 2023	(Q1)Apr 30, 2023	(FY)Jan 31, 2023	(Q4)Jan 31, 2023	(Q3)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	68.92%-284.56K	61.01%-804.51K	28.07%-3.24M	102.71%8.26K	88.34%-273.06K	11.45%-915.45K	-148.92%-2.06M	-16.47%-4.51M	75.36%-304.73K	-80.37%-2.34M
Net income from continuing operations	38.62%-968.61K	51.71%-825.24K	12.75%-5.22M	61.06%-761.66K	6.67%-1.17M	20.71%-1.58M	-118.76%-1.71M	-26.28%-5.98M	-49.59%-1.96M	17.62%-1.25M
Depreciation and amortization	29.84%26.81K	43.34%26.81K	85.69%93.37K	86.20%26.61K	179.05%27.41K	57.75%20.65K	42.97%18.7K	14.71%50.28K	19.18%14.29K	-8.28%9.82K
Remuneration paid in stock	-43.99%102.7K	-52.78%84.42K	43.79%565.01K	-45.95%97.67K	-26.49%105.22K	107.61%183.35K	1,031.83%178.78K	-44.05%392.95K	55.66%180.69K	-9.53%143.14K
Other non cashItems	723.17%60.57K	258.03%23.63K	389.93%50.7K	-1,380.72%-268.41K	1,199.79%305.15K	67.84%7.36K	974.92%6.6K	152.08%10.35K	-1,949.69%-18.13K	2,691.56%23.48K
Change In working capital	9.45%493.98K	79.57%-114.13K	24.43%1.26M	-36.94%914.06K	136.70%457.27K	-47.19%451.33K	-1,220.73%-558.63K	799.59%1.02M	2,586.15%1.45M	-2,535.68%-1.25M
-Change in receivables	-96.91%6.58K	98.75%-636	272.67%347.23K	-51.78%155.19K	105.41%30.26K	599.49%212.65K	-954.61%-50.88K	-15.61%-201.09K	158.66%321.88K	-222.17%-559.31K
-Change in prepaid assets	-1,474.91%-77.64K	-166.62%-7.75K	212.57%66.6K	77.75%52.09K	124.27%7.81K	92.26%-4.93K	57.70%11.64K	-175.27%-59.17K	297.06%29.3K	12.48%-32.16K
-Change in payables and accrued expense	131.94%565.05K	79.64%-105.74K	-33.38%850.2K	-35.65%706.78K	164.06%419.21K	-72.56%243.62K	-833.64%-519.39K	313.84%1.28M	677.68%1.1M	-350.25%-654.42K
Cash from discontinued investing activities
Operating cash flow	68.92%-284.56K	61.01%-804.51K	28.07%-3.24M	102.50%8.26K	88.24%-273.06K	11.11%-915.45K	-148.92%-2.06M	-16.47%-4.51M	73.34%-329.73K	-78.76%-2.32M
Investing cash flow
Cash flow from continuing investing activities	0	0	91.81%-41.35K	103.58%16.26K	79.81%-12.06K	-354.69%-11.46K	-857.60%-34.09K	-6,261.63%-505.07K	-3,026.53%-454.34K	-2,567.98%-59.73K
Net PPE purchase and sale	--0	--0	48.06%-41.35K	164.67%16.26K	77.86%-12.06K	---11.46K	---34.09K	-712.13%-79.61K	-344.65%-25.14K	-2,518.99%-54.48K
Net investment purchase and sale	----	----	--0	----	----	----	----	---429.21K	----	----
Net other investing changes	----	----	----	----	----	----	----	-79.17%3.75K	--0	-216.67%-5.25K
Cash from discontinued investing activities
Investing cash flow	--0	--0	91.81%-41.35K	103.58%16.26K	79.81%-12.06K	-354.69%-11.46K	-857.60%-34.09K	-6,261.63%-505.07K	-3,026.53%-454.34K	-2,567.98%-59.73K
Financing cash flow
Cash flow from continuing financing activities	2,523.37%489.74K	-73.83%805.19K	-18.74%3.2M	-109.36%-26.42K	1,277.96%172.96K	-100.55%-20.21K	10,447.42%3.08M	-4.75%3.94M	60.05%282.33K	-99.39%12.55K
Net issuance payments of debt	-33.79%-27.04K	5,055.63%832.35K	272.60%109.54K	-57.31%-26.42K	1,574.78%172.96K	-15.68%-20.21K	3.86%-16.8K	6.29%-63.46K	28.83%-16.8K	64.56%-11.73K
Net common stock issuance	--0	--0	-39.39%2.6M	--0	--0	--0	--2.6M	77.78%4.3M	--0	--0
Proceeds from stock option exercised by employees	--516.78K	--0	100.00%600K	--0	--0	--0	--600K	50.00%300K	50.00%300K	--0
Net other financing activities	---1	75.61%-27.16K	81.22%-111.35K	--0	--0	--0	-808.03%-111.35K	-137.33%-592.94K	-87,400.00%-873	-53.20%24.28K
Cash from discontinued financing activities
Financing cash flow	2,523.37%489.74K	-73.83%805.19K	-18.74%3.2M	-109.36%-26.42K	1,277.96%172.96K	-100.55%-20.21K	10,447.42%3.08M	-4.75%3.94M	60.05%282.33K	-99.39%12.55K
Net cash flow
Beginning cash position	-99.84%1.67K	-98.81%990	-92.81%83.1K	-99.50%2.9K	-96.10%115.06K	251.49%1.06M	-92.81%83.1K	31.12%1.16M	-73.43%584.84K	106.05%2.95M
Current changes in cash	121.66%205.18K	-99.93%675	92.35%-82.11K	99.62%-1.91K	95.26%-112.16K	-135.73%-947.12K	214.62%979.09K	-491.08%-1.07M	51.98%-501.75K	-408.28%-2.37M
End cash Position	79.78%206.85K	-99.84%1.67K	-98.81%990	-98.81%990	-99.50%2.9K	-96.10%115.06K	251.49%1.06M	-92.81%83.1K	-92.81%83.1K	-73.43%584.84K
Free cash from	69.30%-284.56K	61.64%-804.51K	28.42%-3.29M	106.91%24.52K	88.00%-285.12K	10.00%-926.92K	-153.03%-2.1M	-18.23%-4.59M	71.07%-354.87K	-82.66%-2.38M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

GLAB Gemina Laboratories Ltd

Gemina Laboratories Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow